Cite

    P Emery et al.. “Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis.” Scandinavian journal of rheumatology, vol. 49, 2020, pp. 361–370. http://access.bl.uk/ark:/81055/vdc_100112014407.0x00004a